𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Complete response to alemtuzumab in a patient with B prolymphocytic leukemia

✍ Scribed by Bassem T. Chaar; Paul J. Petruska


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
177 KB
Volume
82
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Rituximab-induced acute thrombocytopenia
✍ GΓΌlsΓΌm Emel Pamuk; Salim Donmez; Burhan Turgut; Muzaffer Demir; Ozden Vural πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 2 views

## HTLV-1-Related Lymphoma in Hong Kong Chinese To the Editor: Human T-cell lymphotropic virus type 1 (HTLV-1) is an endemic infection in Southwest Japan and northern Taiwan [1] with carrier rates from 6% to 37% [2] and a 2.5% lifetime risk of adult T-cell lymphoma leukemia (ATLL). It accounts for

Severe autoimmune hepatitis in a chronic
✍ Steegmann, Juan Luis; Requena, MarΓ­a JosΓ©; GarcΓ­a-Buey, MarΓ­a Luisa; Granados, E πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 19 KB πŸ‘ 2 views

A patient with chronic myeloid leukemia (CML) treated with interferon alpha (IFN alpha) and who developed autoimmune hepatitis (AIH) is described. The patient was treated with IFN alpha 2a, a complete cytogenetic response was achieved 5 months later, and this response has lasted now more than 7 year